158 related articles for article (PubMed ID: 15498851)
1. Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of alpha beta-TCR+ and CD4+ cells negates the effect.
Ildstad ST; Chilton PM; Xu H; Domenick MA; Ray MB
Blood; 2005 Mar; 105(6):2577-84. PubMed ID: 15498851
[TBL] [Abstract][Full Text] [Related]
2. Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade.
Bozulic LD; Huang Y; Xu H; Wen Y; Ildstad ST
Exp Hematol; 2011 Oct; 39(10):977-85. PubMed ID: 21726515
[TBL] [Abstract][Full Text] [Related]
3. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
4. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.
Taylor PA; Lees CJ; Waldmann H; Noelle RJ; Blazar BR
Blood; 2001 Jul; 98(2):467-74. PubMed ID: 11435318
[TBL] [Abstract][Full Text] [Related]
5. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.
Nikolic B; Onoe T; Takeuchi Y; Khalpey Z; Primo V; Leykin I; Smith RN; Sykes M
Transplantation; 2010 Jan; 89(1):23-32. PubMed ID: 20061915
[TBL] [Abstract][Full Text] [Related]
6. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
7. Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb.
Liang Y; Huang T; Zhang C; Todorov I; Atkinson M; Kandeel F; Forman S; Zeng D
Blood; 2005 Mar; 105(5):2180-8. PubMed ID: 15374883
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
Zhu ZX; Fan LY; Wang Q
Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
[TBL] [Abstract][Full Text] [Related]
9. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
[TBL] [Abstract][Full Text] [Related]
10. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells.
Kurtz J; Ito H; Wekerle T; Shaffer J; Sykes M
Am J Transplant; 2001 Nov; 1(4):339-49. PubMed ID: 12099378
[TBL] [Abstract][Full Text] [Related]
13. CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow.
Xu H; Exner BG; Cramer DE; Tanner MK; Mueller YM; Ildstad ST
J Immunol; 2002 Feb; 168(4):1636-43. PubMed ID: 11823491
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
15. Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.
Graca L; Daley S; Fairchild PJ; Cobbold SP; Waldmann H
BMC Immunol; 2006 Apr; 7():9. PubMed ID: 16638128
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
17. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
Kurtz J; Raval F; Vallot C; Der J; Sykes M
Blood; 2009 Apr; 113(15):3475-84. PubMed ID: 19179471
[TBL] [Abstract][Full Text] [Related]
19. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.
Seung E; Iwakoshi N; Woda BA; Markees TG; Mordes JP; Rossini AA; Greiner DL
Blood; 2000 Mar; 95(6):2175-82. PubMed ID: 10706892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]